Changes in cognitive appraisal in a randomized controlled trial of mindfulness-based cognitive therapy for patients with migraine

被引:2
|
作者
Kruse, Jessica A. [1 ,4 ]
Seng, Elizabeth K. [1 ,2 ,3 ]
机构
[1] Yesh Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA
[2] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY USA
[3] Montefiore Headache Ctr, Montefiore Med Ctr, Bronx, NY USA
[4] Yesh Univ, Ferkauf Grad Sch Psychol, 1165 Morris Pk Ave, Bronx, NY 10461 USA
来源
HEADACHE | 2023年 / 63卷 / 10期
关键词
metacognition; migraine; mindfulness; pain catastrophizing; BEHAVIORAL THERAPY; STRESS REDUCTION; CHRONIC PAIN; DISABILITY; FUSION; WOMEN; MODEL;
D O I
10.1111/head.14627
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThis study is a secondary analysis evaluating changes in cognitive fusion and pain catastrophizing over 8 weeks of mindfulness-based cognitive therapy for migraine (MBCT-M) intervention versus waitlist/treatment as usual.BackgroundMigraine is a common disabling neurological condition. MBCT-M combines elements of cognitive behavioral therapy with mindfulness-based approaches and has demonstrated efficacy in reducing migraine-related disability.MethodsA total of 60 adults with migraine completed a 30-day run-in before randomization into a parallel design of either eight weekly individual MBCT-M sessions (n = 31) or waitlist/treatment as usual (n = 29): participants were followed for 1 month after. Participants completed the Pain Catastrophizing Scale (PCS) and the Cognitive Fusion Questionnaire (CFQ) at Months 0, 1, 2, and 4.ResultsThe PCS scores decreased more in the MBCT-M group (mean [SD] at baseline = 22.5 [9.6]; at Month 4 = 15.1 [8.8]) than in the waitlist/treatment as usual group (mean [SD] at baseline = 24.9 [9.0]; at Month 4 = 22.5 [10.4]) from Month 0 to 4 (beta = -7.24, p = 0.001, 95% confidence interval [CI] -11.39 to -3.09). The CFQ (mean [SD] baseline = 27.6 [8.0]; at Month 4 = 25.0 [8.0]) did not change significantly from Month 0 to 4 (beta = -1.2, p = 0.482, 95% CI -4.5 to 2.1). Parallel mediation analyses indicated that decreases in the PCS and CFQ together (beta = -6.1, SE = 2.5, 95% CI -11.6 to -1.8), and the PCS alone (beta = -4.8, SE = 2.04, 95% CI -9.1 to -1.1), mediated changes in headache disability in the MBCT-M treatment completer group (n = 19).ConclusionIn this study, pain catastrophizing showed strong promise as a potential mechanism of MBCT-M. Future research should continue to explore cognitive appraisal changes in mindfulness-based interventions.
引用
下载
收藏
页码:1403 / 1411
页数:9
相关论文
共 50 条
  • [21] Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial
    Tovote, K. Annika
    Fleer, Joke
    Snippe, Evelien
    Peeters, Anita C. T. M.
    Emmelkamp, Paul M. G.
    Sanderman, Robbert
    Links, Thera P.
    Schroevers, Maya J.
    DIABETES CARE, 2014, 37 (09) : 2427 - 2434
  • [22] Mindfulness-based cognitive therapy and cognitive behavioral therapy for chronic pain in multiple sclerosis: a randomized controlled trial protocol
    Dawn M. Ehde
    Kevin N. Alschuler
    Melissa A. Day
    Marcia A. Ciol
    Makena L. Kaylor
    Jennifer K. Altman
    Mark P. Jensen
    Trials, 20
  • [23] Mindfulness-based cognitive therapy and cognitive behavioral therapy for chronic pain in multiple sclerosis: a randomized controlled trial protocol
    Ehde, Dawn M.
    Alschuler, Kevin N.
    Day, Melissa A.
    Ciol, Marcia A.
    Kaylor, Makena L.
    Altman, Jennifer K.
    Jensen, Mark P.
    TRIALS, 2019, 20 (01)
  • [24] Mindfulness-based cognitive therapy in functional dyspepsia: A pilot randomized trial
    Teh, Kevin Kim-Jun
    Ng, Yi-Kang
    Doshi, Kinjal
    Tay, Shu-Wen
    Hao, Ying
    Ang, Lui-Yee
    Foong, Henry Lew-Yuen
    Ong, Andrew Ming-Liang
    Siah, Kewin Tien-Ho
    Chan, Webber Pak-Wo
    Ong, Wai-Choung
    Mesenas, Steven Joseph
    Lim, Chee-Hooi
    Wang, Yu-Tien
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2058 - 2066
  • [25] Mindfulness-Based Stress Reduction and Mindfulness-Based Cognitive Therapy - a systematic review of randomized controlled trials
    Fjorback, L. O.
    Arendt, M.
    Ornbol, E.
    Fink, P.
    Walach, H.
    ACTA PSYCHIATRICA SCANDINAVICA, 2011, 124 (02) : 102 - 119
  • [26] Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial
    Farver-Vestergaard, Ingeborg
    O'Toole, Mia S.
    O'Connor, Maja
    Lokke, Anders
    Bendstrup, Elisabeth
    Basdeo, Sharee A.
    Cox, Donal J.
    Dunne, Padraic J.
    Ruggeri, Kai
    Early, Frances
    Zachariae, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (02)
  • [27] Response to Mindfulness-Based Cognitive Therapy for Migraine in Chronic and Episodic Migraine: Planned Secondary Analyses of a Randomized Clinical Trial
    Seng-Tamaccio, Elizabeth K.
    Singer, Alexandra B.
    Metts, Christopher
    Grinberg, Amy S.
    Patel, Zarine S.
    Marzouk, Maya
    Rosenberg, Lauren
    Day, Melissa
    Minen, Mia T.
    Buse, Dawn C.
    Lipton, Richard B.
    ANNALS OF NEUROLOGY, 2019, 86 : S265 - S265
  • [28] Mindfulness-based cognitive therapy for multiple chemical sensitivity: a study protocol for a randomized controlled trial
    Christian Riise Hauge
    Peter Jensa E Bonde
    Alice Rasmussen
    Sine Skovbjerg
    Trials, 13
  • [29] Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial
    Cladder-Micus, Mira B.
    Speckens, Anne E. M.
    Vrijsen, Janna N.
    Donders, A. Rogier T.
    Becker, Eni S.
    Spijker, Jan
    DEPRESSION AND ANXIETY, 2018, 35 (10) : 914 - 924
  • [30] Response to Mindfulness-Based Cognitive Therapy for Migraine in Chronic and Episodic Migraine: Planned Secondary Analyses of a Randomized Clinical Trial
    Seng, E. K.
    Singer, A.
    Metts, C.
    Grinberg, A. S.
    Patel, Z.
    Marzouk, M.
    Rosenberg, L.
    Day, M.
    Minen, M.
    Buse, D.
    Lipton, R. B.
    HEADACHE, 2019, 59 : 206 - 207